锦欣生殖(01951)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01951 锦欣生殖

未开盘 03-28 16:08:43

5.240

-0.160

-2.96%

最高5.430	最低5.210	成交量2,276万
今开5.400	昨收5.400	日振幅4.07%
总市值142.58亿	流通市值142.58亿	总股本27.21亿
成交额1.20亿	换手率0.84%	流通股本27.21亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01951","market":"HK","secType":"STK","nameCN":"锦欣生殖","latestPrice":5.24,"timestamp":1679990923014,"preClose":5.4,"halted":0,"volume":22756500,"delay":0,"floatShares":2720913796,"shares":2720913796,"eps":0.1564868,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.16,"latestTime":"03-28 16:08:43","open":5.4,"high":5.43,"low":5.21,"amount":119811438,"amplitude":0.040741,"askPrice":5.24,"askSize":5500,"bidPrice":5.23,"bidSize":159000,"shortable":3,"etf":0,"ttmEps":0.16490699915223636,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1680053400000},"adr":0,"listingDate":1561392000000,"adjPreClose":5.4,"dividendRate":0.013062,"volumeRatio":0.8823335365180827,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01951","defaultTab":"news","newsList":[{"id":"2321943591","title":"锦欣生殖3月22日获南向资金加仓672.25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2321943591","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2321943591?lang=zh_CN&edition=full","pubTime":"2023-03-23 09:31","pubTimestamp":1679535101,"startTime":"0","endTime":"0","summary":"3月22日, 南向资金增持锦欣生殖672.25万股。截止当日收盘，港股通共持有锦欣生殖84536.04万股，占流通股31.06%。锦欣生殖近5个交易日上涨3.83%，港股通累计增持1391.35万股；近20个交易日下跌13.97%，港股通累计减持2406.30万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303230936028355d280&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303230936028355d280&s=b","is_publish_highlight":false},{"id":"2319818248","title":"锦欣生殖(01951.HK)拟3月30日举行董事会会议审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2319818248","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2319818248?lang=zh_CN&edition=full","pubTime":"2023-03-15 17:47","pubTimestamp":1678873665,"startTime":"0","endTime":"0","summary":"格隆汇3月15日丨锦欣生殖(01951.HK)发布公告，公司谨订于2023年3月30日（星期四）举行董事会会议，藉以（其中包括）考虑及批准集团截至2022年12月31日止年度的年度业绩及其发布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303151747508419dd4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303151747508419dd4d&s=b","is_publish_highlight":false},{"id":"2319854722","title":"锦欣生殖3月14日遭南向资金减持768.44万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2319854722","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2319854722?lang=zh_CN&edition=full","pubTime":"2023-03-15 09:31","pubTimestamp":1678843914,"startTime":"0","endTime":"0","summary":"3月14日，南向资金减持锦欣生殖768.44万股。截止当日收盘，港股通共持有锦欣生殖84030.76万股，占流通股30.87%。锦欣生殖近5个交易日下跌16.91%，港股通累计减持2277.46万股；近20个交易日下跌23.91%，港股通累计减持2496.18万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303150935258061bd89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303150935258061bd89&s=b","is_publish_highlight":false},{"id":"2319041264","title":"《大行报告》瑞信下调锦欣生殖(01951.HK)目标价至8元  评级“跑赢大市”","url":"https://stock-news.laohu8.com/highlight/detail?id=2319041264","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2319041264?lang=zh_CN&edition=full","pubTime":"2023-03-14 09:48","pubTimestamp":1678758480,"startTime":"0","endTime":"0","summary":"瑞信发表报告指，锦欣生殖上周股价跌幅较同业大，下跌约20%，对比海吉亚医疗为下跌约10%，固生堂为下跌约8%。不过，该行认为锦欣生殖的基本面未见重大改变，且其限制性股票授予计划中15%的利润增长目标属保守。瑞信下调锦欣生殖股份目标价，由9元降至8元，评级维持“跑赢大市”，并调低集团2022年至2024年每股盈利预测分别10.4%、11.2%及12.7%。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190625095102761_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190625095102761_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1251370/latest-news/HK6","is_publish_highlight":false},{"id":"2319309033","title":"西南证券：政策助推行业发展 辅助生殖开启黄金发展十年","url":"https://stock-news.laohu8.com/highlight/detail?id=2319309033","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2319309033?lang=zh_CN&edition=full","pubTime":"2023-03-13 13:50","pubTimestamp":1678686650,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，西南证券发布研究报告称，辅助生殖市场空间广阔，政策助力提升行业渗透率。③辅助生殖差异化需求未被满足，客单价未来有望持续提升。目前我国批准开展人类辅助生殖技术的医疗机构共523家，人类精子库的医疗机构共27家。1)新生儿下降趋势下试管婴儿仍快速增长。美国：新生儿人口数量自2007年起逐年下降，2020年新生儿数量约为361万。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/890698.html","is_publish_highlight":false},{"id":"2319708387","title":"锦欣生殖3月10日遭南向资金减持1027.61万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2319708387","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2319708387?lang=zh_CN&edition=full","pubTime":"2023-03-13 09:31","pubTimestamp":1678671119,"startTime":"0","endTime":"0","summary":"3月10日，南向资金减持锦欣生殖1027.61万股。截止当日收盘，港股通共持有锦欣生殖84664.95万股，占流通股31.11%。锦欣生殖近5个交易日下跌21.96%，港股通累计减持1526.21万股；近20个交易日下跌20.18%，港股通累计减持1813.48万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023031309355782bad8ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023031309355782bad8ee&s=b","is_publish_highlight":false},{"id":"2319832560","title":"锦欣生殖集团成功召开2022年度质控总结会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2319832560","media":"JXR锦欣生殖","top":-1,"share":"https://www.laohu8.com/m/news/2319832560?lang=zh_CN&edition=full","pubTime":"2023-03-13 09:00","pubTimestamp":1678669200,"startTime":"0","endTime":"0","summary":"2023年3月3日，锦欣生殖集团质控部在成都西囡妇科医院召开2022年度质控总结会议，集团旗下6家医院均派代表出席。会上，锦欣生殖集团首席医疗官李媛教授提出，2023年各院区在快速发展的同时应以质量为先，始终将医疗质量放在第一位，在提升服务质量的同时，进一步完善患者的服务体验。至此，锦欣生殖集团2022年度质控总结会议圆满结束。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzUwOTg5MDE0NA==&mid=2247491532&idx=1&sn=d7b6fd6bb27760061337c53dc48906c1&chksm=f90a04c3ce7d8dd52761284e48f930b74abdb527944c6f76db89d3fca10e079929a64f14c724#rd","is_publish_highlight":false},{"id":"2318760232","title":"锦欣生殖盘中异动 大幅跳水5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2318760232","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2318760232?lang=zh_CN&edition=full","pubTime":"2023-03-10 15:10","pubTimestamp":1678432239,"startTime":"0","endTime":"0","summary":"2023年03月10日下午盘15时10分，锦欣生殖股票出现波动，股价大幅跳水5.13%。截至发稿，该股报5.200港元/股，成交量3235.85万股，换手率1.19%，振幅3.65%。锦欣生殖股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，正大企业国际、3D MEDICINES-B、康诺亚-B涨幅较大，振幅较大的相关个股有正大企业国际、莲和医疗、康诺亚-B，振幅分别为27.35%、11.90%、10.79%。管理服务部门向锦江生殖中心及锦欣生育中心提供共同管理服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230310151039835332d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230310151039835332d9&s=b","is_publish_highlight":false},{"id":"2318327254","title":"锦欣生殖(01951)出现大手卖出77万股，成交价$5.48，涉资421.96万","url":"https://stock-news.laohu8.com/highlight/detail?id=2318327254","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2318327254?lang=zh_CN&edition=full","pubTime":"2023-03-09 16:08","pubTimestamp":1678349280,"startTime":"0","endTime":"0","summary":"[大手成交]锦欣生殖(01951)在下午04:08出现大手卖出，成交量为77万，成交价为港币$5.48，涉资421.96万。至目前为止，股价跌4.363%，今日最高价为$5.79，而最低价为$5.45，总成交量为3.752千万股，总成交金额港币$2.082亿。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2303094084/aamm-all-category","is_publish_highlight":false},{"id":"2317519458","title":"锦欣生殖(01951)股价下跌5.046%，现价港币$6.21","url":"https://stock-news.laohu8.com/highlight/detail?id=2317519458","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2317519458?lang=zh_CN&edition=full","pubTime":"2023-03-07 13:50","pubTimestamp":1678168200,"startTime":"0","endTime":"0","summary":"[下跌股]锦欣生殖(01951) 股价在下午01:50比前收市价下跌5.046%，现股价为港币$6.21。至目前为止，今日最高价为$6.56，而最低价为$6.21。总成交量为1.671千万股，总成交金额为港币$1.059亿。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2303072062/aamm-all-category","is_publish_highlight":false},{"id":"2316667344","title":"锦欣生殖上升近7% 机构指估值具有吸引力","url":"https://stock-news.laohu8.com/highlight/detail?id=2316667344","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2316667344?lang=zh_CN&edition=full","pubTime":"2023-03-01 15:25","pubTimestamp":1677655521,"startTime":"0","endTime":"0","summary":"锦欣生殖午盘续涨，涨6.89%，报6.67港元，成交额2.19亿港元。　　近日，里昂发布研究报告称，维持锦欣生殖“买入”评级，预计2021-2025年间收入年均复合增长率将达20%，每股盈利年均复合增长率有望达24%，目标价由9港元下调至8.4港元，估值具吸引力。　　报告中称，作为中国最大的私人辅助生殖服务提供商，公司于2021财年市场份额为4.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-03-01/doc-imyiiyew9582438.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-03-01/doc-imyiiyew9582438.shtml","is_publish_highlight":false},{"id":"2316865728","title":"港股异动 | 锦欣生殖(01951)升6% 机构指需求料持续修复 公司增长确定性进一步提高","url":"https://stock-news.laohu8.com/highlight/detail?id=2316865728","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2316865728?lang=zh_CN&edition=full","pubTime":"2023-03-01 11:49","pubTimestamp":1677642564,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，锦欣生殖早盘回暖，涨约6%。截至发稿，锦欣生殖涨6.09%，报6.62港元，成交额1.35亿港元。近日，里昂发布锦欣生殖更新报告指，中国辅助生殖服务市场将在2022至2025年录得12%的年均复合增长率，预计锦欣生殖将在2021至25年期间，收入年均复合增长率料达20%，维持“买入”评级。前期积压需求有望得到持续修复，预计2023年公司各大院区均实现良性增长。预计22-24年归母净利润为3.59/6.04/7.91亿元，维持“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/884970.html","is_publish_highlight":false},{"id":"2316465914","title":"锦欣生殖盘中异动 快速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2316465914","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2316465914?lang=zh_CN&edition=full","pubTime":"2023-03-01 10:21","pubTimestamp":1677637261,"startTime":"0","endTime":"0","summary":"2023年03月01日早盘10时21分，锦欣生殖股票出现异动，股价大幅拉升5.13%。截至发稿，该股报6.560港元/股，成交量721.95万股，换手率0.27%，振幅4.49%。资金方面，该股资金流入2510.46万港元，流出1136.66万港元。锦欣生殖股票所在的生物技术行业中，整体涨幅为1.08%。锦欣生殖公司简介：锦欣生殖医疗集团有限公司是一家主要提供辅助生殖服务的中国公司。管理服务部门向锦江生殖中心及锦欣生育中心提供共同管理服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023030110210282b93545&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023030110210282b93545&s=b","is_publish_highlight":false},{"id":"2316107659","title":"锦欣生殖(01951)股价上升5.128%，现价港币$6.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2316107659","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2316107659?lang=zh_CN&edition=full","pubTime":"2023-03-01 10:20","pubTimestamp":1677637200,"startTime":"0","endTime":"0","summary":"[上升股]锦欣生殖(01951) 股价在上午10:20比前收市价上升5.128%，现股价为港币$6.56。至目前为止，今日最高价为$6.56，而最低价为$6.28。总成交量为720.55万股，总成交金额为港币$4.628千万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2303015314/aamm-all-category","is_publish_highlight":false},{"id":"2314905561","title":"锦欣生殖召开2023年合规绩效考核工作会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2314905561","media":"JXR锦欣生殖","top":-1,"share":"https://www.laohu8.com/m/news/2314905561?lang=zh_CN&edition=full","pubTime":"2023-02-27 09:00","pubTimestamp":1677459600,"startTime":"0","endTime":"0","summary":"加强合规管理 促进稳健经营2023年2月23日，锦欣生殖集团成功召开2023年合规绩效考核管理工作会议，锦欣生殖董事长钟勇先生、CO-CEO吕蓉女士、COO段红梅女士等出席会议。国家医保局答复称，将逐步把适宜的分娩镇痛和辅助生殖技术项目纳入医保基金支付范围，减轻不孕不育患者医疗负担。具体而言，锦欣生殖的考核管理办法践行“三步走”原则。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzUwOTg5MDE0NA==&mid=2247491415&idx=1&sn=d093e1800b3d731b050d8bf61d604c98&chksm=f90a0458ce7d8d4efa58c17be5d6a6db4849b5bd00b1cea65ebc5407b4f9959867802f956f5a#rd","is_publish_highlight":false},{"id":"2314561909","title":"聚焦医疗安全与品质 促进医院高质量发展——锦欣生殖集团质控部深入武汉锦欣中西医结合妇产医院开展督查工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2314561909","media":"JXR锦欣生殖","top":-1,"share":"https://www.laohu8.com/m/news/2314561909?lang=zh_CN&edition=full","pubTime":"2023-02-27 09:00","pubTimestamp":1677459600,"startTime":"0","endTime":"0","summary":"为进一步加强医疗质量管理，保障医疗安全，2023年2月13日至15日，由锦欣生殖集团质控部、督查办专家组成的督导组深入武汉锦欣中西医结合妇产医院开展综合督查指导工作。此外，夏明静院长提出，希望以本次检查为契机，以查促建、以查促改，进一步提升武汉锦欣中西医结合妇产医院的医疗品质和医疗安全水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzUwOTg5MDE0NA==&mid=2247491415&idx=2&sn=7e1a01913291c8fbdba8c513c2410607&chksm=f90a0458ce7d8d4e2586086c6202cb5c6cd5b33d08e21bc24d51e8e66911ef2002e8cfc71283#rd","is_publish_highlight":false},{"id":"2313024200","title":"港股三胎概念股走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2313024200","media":"和讯","top":-1,"share":"https://www.laohu8.com/m/news/2313024200?lang=zh_CN&edition=full","pubTime":"2023-02-23 09:39","pubTimestamp":1677116350,"startTime":"0","endTime":"0","summary":"快讯摘要港股三胎概念股走高：港股三胎概念股走高，锦欣生殖涨锦4%，H&H国际控股涨近3%，贝康医疗、中国飞鹤等跟涨。快讯正文港股三胎概念股走高：港股三胎概念股走高，锦欣生殖涨锦4%，H&H国际控股涨近3%，贝康医疗、中国飞鹤等跟涨。下载和讯APP查看快讯，体验更佳>>","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202302230950358411f95c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202302230950358411f95c&s=b","is_publish_highlight":false},{"id":"2313129724","title":"【初心• 明志• 匠心•致远】热烈庆祝深圳中山泌尿外科医院生殖医学中心发表SCI论文突破100篇","url":"https://stock-news.laohu8.com/highlight/detail?id=2313129724","media":"JXR锦欣生殖","top":-1,"share":"https://www.laohu8.com/m/news/2313129724?lang=zh_CN&edition=full","pubTime":"2023-02-20 09:00","pubTimestamp":1676854800,"startTime":"0","endTime":"0","summary":"-深圳中山泌尿外科医院-100篇SCI论文庆典初心 明志 匠心致远01开幕2月18日下午，深圳中山泌尿外科医院在学术报告厅举行了主题为“初心 明志 匠心致远”100篇SCI论文庆典活动。100篇SCI论文是深圳中山泌尿外科医院发表SCI论文之路的第一个十年的终点，也是下一个十年的崭新起点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzUwOTg5MDE0NA==&mid=2247490994&idx=1&sn=18e3290c2c1a94be647efd6369f27244&chksm=f90a06bdce7d8fabd1e1ad98528fb67ac296bb762faba199832f1527b2faeecf88314d16f450#rd","is_publish_highlight":false},{"id":"2312404312","title":"降低“三育”成本，多地出台积极生育支持政策，婴童概念股再度走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2312404312","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2312404312?lang=zh_CN&edition=full","pubTime":"2023-02-17 11:34","pubTimestamp":1676604863,"startTime":"0","endTime":"0","summary":"催生大作战","market":"us","thumbnail":"https://img3.gelonghui.com/7a347-1e084550-9758-4140-9aa9-f9ca45da785e.jpg","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/7a347-1e084550-9758-4140-9aa9-f9ca45da785e.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/580408","is_publish_highlight":false},{"id":"2311464126","title":"里昂：维持锦欣生殖买入评级 目标价8.4港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2311464126","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2311464126?lang=zh_CN&edition=full","pubTime":"2023-02-16 12:29","pubTimestamp":1676521788,"startTime":"0","endTime":"0","summary":"里昂发布研究报告称，维持锦欣生殖（01951）“买入”评级，预计2021-25年间收入年均复合增长率将达20%，每股盈利年均复合增长率有望达24%，目标价由9港元下调至8.4港元，估值具吸引力。\n　　报告中称，作为中国最大的私人辅助生殖服务（ARS）提供商，公司于2021财年市场份额为4.8%。该行预计，中国ARS市场将在2022-25年取得12%的年均复合增长率，又相信集团将透过并购和高端服务保持其在私人市场领导地位。\n\n炒股开户享福利，入金抽188元红包，100%中奖！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2023-02-16/doc-imyfwimu9003521.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2023-02-16/doc-imyfwimu9003521.shtml","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0242},{"period":"1month","weight":-0.1589},{"period":"3month","weight":-0.3013},{"period":"6month","weight":0.347},{"period":"1year","weight":-0.1288},{"period":"ytd","weight":-0.2732}],"websiteUrl":"http://www.jxr-fertility.com","compareEarnings":[{"period":"1week","weight":0.0273},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.0057},{"period":"6month","weight":0.1526},{"period":"1year","weight":-0.0876},{"period":"ytd","weight":0.0002}],"name":"锦欣生殖","description":"锦欣生殖医疗集团有限公司是一家主要提供辅助生殖服务的中国公司。该公司通过三个业务部门开展业务。辅助生殖服务部门主要为患者提供两种治疗方案：人工受精（AI）及体外受精（IVF）技术。管理服务部门向锦江生殖中心及锦欣生育中心提供共同管理服务。辅助医疗服务部门主要通过深圳中山医院提供妇科、泌尿外科及内科等领域的医疗服务。该公司主要在中国和美国开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.025956},{"month":2,"riseRate":0.5,"avgChangeRate":0.025398},{"month":3,"riseRate":0,"avgChangeRate":-0.170438},{"month":4,"riseRate":0.666667,"avgChangeRate":0.05904},{"month":5,"riseRate":1,"avgChangeRate":0.132206},{"month":6,"riseRate":0.666667,"avgChangeRate":0.064739},{"month":7,"riseRate":0.25,"avgChangeRate":-0.093325},{"month":8,"riseRate":0.25,"avgChangeRate":-0.079924},{"month":9,"riseRate":0.25,"avgChangeRate":-0.056723},{"month":10,"riseRate":0.5,"avgChangeRate":0.04737},{"month":11,"riseRate":0.5,"avgChangeRate":0.203685},{"month":12,"riseRate":0.5,"avgChangeRate":0.008809}],"exchange":"SEHK","nameEN":"JXR","compareStock":{"symbol":"HSI","name":"恒生指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.12.1","shortVersion":"4.12.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"锦欣生殖(01951)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供锦欣生殖(01951)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"锦欣生殖,01951,锦欣生殖股票,锦欣生殖股票老虎,锦欣生殖股票老虎国际,锦欣生殖行情,锦欣生殖股票行情,锦欣生殖股价,锦欣生殖股市,锦欣生殖股票价格,锦欣生殖股票交易,锦欣生殖股票购买,锦欣生殖股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"锦欣生殖(01951)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供锦欣生殖(01951)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}